Table 4: The significantly differed parameters of the MACE groups in univariate analyses.
Parameters |
MACE (-) (262) |
MACE (+) (50) |
P value |
Age (years) |
61 ± 12 |
65 ± 11 |
0.046 |
Intracoronary nitrate use (%) |
69.9 |
51.4 |
0.028 |
Intracoronary nitrate (mcg) |
199 ± 8 |
190 ± 42 |
0.010 |
USAP-NSTEMI (%) STEMI (%) |
61.8 38.2 |
40 60 |
0.014 |
Hypertension (%) |
50 |
68.6 |
0.038 |
Post-dilatation (%) |
18.5 |
34.3 |
0.029 |
Delta CK-MB (ng/ml) |
47 ± 81 |
91 ± 118 |
0.005 |
Peak Troponin-I (ng/ml) |
21 ± 21 |
31 ± 21 |
0.011 |
Admission blood glucose (mg/dl) |
146 ± 71 |
174 ± 76 |
0.031 |
Hba1c |
6.6 ± 1.7 |
7.3 ± 2.2 |
0.027 |
Creatinine (mg/dl) |
0.97 ± 0.32 |
1.12 ± 0.44 |
0.002 |
Leukocytes (103/mm3) |
9.98 ± 3.17 |
11.9 ± 4.77 |
0.001 |
Medications |
|
|
|
ASA (%) |
22.4 |
42.9 |
0.008 |
BB (%) |
19.9 |
45.7 |
0.001 |
PPI (%) |
12.1 |
25.7 |
0.028 |
Pain-to-balloon time/(min) |
221.77 ± 121 |
206.68 ± 108 |
0.072 |
USAP: Unstable Angina Pectoris; NSTEMI: Non-ST Elevated Myocardial Infarction; STEMI: ST-Elevated Myocardial Infarction; CK-MB: Creatinine Kinase Myocardial Band; ASA: Acetylsalicylic Acid; BB: Beta Blockers; PPI: Proton Pump Inhibitors